Suchergebnisse - "Ansell, Stephen M"

PubPharm (741)

1

Secreted ORF8 is a pathogenic cause of severe COVID-19 and is potentially targetable with select NLRP3 inhibitors

enthalten in: bioRxiv.org | 2024

von Wu, X. | Manske, M. | Ruan, G. | +16

2

Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy

enthalten in: Transplantation and cellular therapy | 2024

von Bansal, R. | Vergidis, P. | Tosh, P. | +11

3

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

enthalten in: Blood advances | 2024

von Zinzani, P. | Salles, G. | Moskowitz, A. | +17

4

Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments

enthalten in: Cell reports. Medicine | 2024

von Krull, J. | Wenzl, K. | Hopper, M. | +18

5

Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma : implications for radiation therapy

enthalten in: Blood advances | 2024

von Burlile, J. | Frechette, K. | Breen, W. | +18

6

Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma : the Mayo Clinic experience

enthalten in: Leukemia & lymphoma | 2024

von Chohan, K. | Bansal, R. | Hathcock, M. | +11

7

Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy

enthalten in: Haematologica | 2024

von Tun, A. | Wang, Y. | Maliske, S. | +12

8

Precision Cancer Therapies, Immunologic Approaches for the Treatment of Lymphoid Malignancies : From Concept to Practice

Erschienen: Newark, John Wiley & Sons, Incorporated, 2024

1st ed.

von O'Connor, O. | Ansell, S. | Gribben, J.

9

Immunologic approaches for the treatment of lymphoid malignancies : from concept to practice

Erschienen: Hoboken, NJ, Wiley Blackwell, 2024

Precision cancer therapies - volume 2

von Gribben, J. | O'Connor, O. | Ansell, S.

10

Day 100 Natural Killer Cell/CD14+HLA-DRDIM ratio and survival in lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation

enthalten in: Clinical transplantation | 2024

von Porrata, L. | Ansell, S. | Micallef, I. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[75]